Showing 51-60 of 490 results for "".
Skin Priming
https://modernaesthetics.com/topics/skincare/skin-priming/35396/Meeting Notes
https://modernaesthetics.com/ma-issues-index/2013-jan-feb/meeting-notes/34813/News from recent meetings, and a guide to upcoming events.Where Are We in 2023? A Q&A on Botulinum Toxins
https://modernaesthetics.com/ma-issues-index/2023-nov-dec/where-are-we-in-2023-a-qa-on-botulinum-toxins/35332/Sue Ellen Cox, MD, describes what she is seeing in the evolving neuromodulators landscapeDishing on a New Neuromodulator
https://modernaesthetics.com/topics/injectables/dishing-on-a-new-neuromodulator/35248/Sound strategies are required for patient counseling, dosing, and pricing with daxibotulinumtoxinA-lanm.Where Are We in 2024? A Q&A on Non-Surgical Skin Tightening
https://modernaesthetics.com/ma-issues-index/2024-jan-feb/where-are-we-in-2024-a-qa-on-non-surgical-skin-tightening/35344/Anne Chapas, MD, and Erez Dayan, MD, share insights into the latest developments in non-surgical skin tightening.Advalight’s ADVATx Laser
https://modernaesthetics.com/ma-issues-index/2024-mar-apr/advalights-advatx-laser/35352/Exosome Therapy for Pelvic Tissue Regeneration
https://modernaesthetics.com/ma-issues-index/september-october-2025/exosome-therapy-for-pelvic-tissue-regeneration/39268/Preclinical studies highlight potential applications for vaginal mesh complications, anal sphincter injury, and urinary incontinenceObagi’s Skintrinsiq System
https://modernaesthetics.com/topics/skincare/obagis-skintrinsiq-system/35124/Sciton’s Joule X Platform
https://modernaesthetics.com/ma-issues-index/2020-jan-feb/scitons-joule-x-platform/34856/In each issue, Modern Aesthetics® magazine asks top cosmetic physicians about the devices that they are introducing to their patients. Here, Arisa Ortiz, MD, an Assistant Clinical Professor of Dermatology and Director of Laser and Cosmetic Dermatology at UC San Diego, shares her experience with ScitComing & Going: March/April 2023
https://modernaesthetics.com/topics/skincare/coming-going-marchapril-2023/35268/Everyone is taking Ozempic/Wegovy (semaglutide, Novo Nordisk) or Mounjaro (tirzepatide, Lilly) for weight loss–many of whom may need to lose weight, rein in their diabetes, or both.